The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure

The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure

Abstract Aims No studies have comprehensively compared the efficacy of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, renin–angiotensin system (RAS) inhibitors, and angiotensin receptor neprilysin (ARN) inhibitors based on different type of heart failure, including heart failure with reduced eje...

Full description

Bibliographic Details
Main Authors: Peng‐juan Ji, Zhuo‐ya Zhang, Qi Yan, Hui‐li Cao, Ya‐jing Zhao, Bin Yang, Jin Li
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Cardiovascular outcome
SGLT2 inhibitors
RAS inhibitors
ARN inhibitors
Network meta‐analysis
Online Access:https://doi.org/10.1002/ehf2.14298

Internet

https://doi.org/10.1002/ehf2.14298

Similar Items